| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:32:15 UTC |
|---|
| Update Date | 2023-02-21 17:19:08 UTC |
|---|
| HMDB ID | HMDB0029723 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Saccharin |
|---|
| Description | Saccharin, also known as benzosulfimide or O-sulfobenzimide, belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). Saccharin is a bitter and odorless tasting compound. Saccharin has been detected, but not quantified in, milk (cow). This could make saccharin a potential biomarker for the consumption of these foods. Saccharin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a small amount of articles have been published on Saccharin. |
|---|
| Structure | OC1=NS(=O)(=O)C2=CC=CC=C12 InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| 1,1-Dioxo-1,2-benzisothiazol-3(2H)-one | ChEBI | | 1,1-Dioxo-1,2-dihydro-benzo[D]isothiazol-3-one | ChEBI | | 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide | ChEBI | | 1,2-Benzisothiazolin-3-one 1,1-dioxide | ChEBI | | 1,2-Dihydro-2-ketobenzisosulfonazole | ChEBI | | 1,2-Dihydro-2-ketobenzisosulphonazole | ChEBI | | 2,3-Dihydro-3-oxobenzisosulfonazole | ChEBI | | 2,3-Dihydro-3-oxobenzisosulphonazole | ChEBI | | 3-Hydroxybenzisothiazole-S,S-dioxide | ChEBI | | Anhydro-O-sulfaminebenzoic acid | ChEBI | | Benzo-2-sulphimide | ChEBI | | Benzoic acid sulfimide | ChEBI | | Benzoic sulfimide | ChEBI | | Benzoic sulphimide | ChEBI | | Benzosulfimide | ChEBI | | Benzosulphimide | ChEBI | | Benzoylsulfonic imide | ChEBI | | O-Benzoic sulfimide | ChEBI | | O-Benzosulfimide | ChEBI | | O-Sulfobenzimide | ChEBI | | O-Sulfobenzoic acid imide | ChEBI | | Saccharimide | ChEBI | | Saccharine | ChEBI | | Sweeta | Kegg | | Anhydro-O-sulfaminebenzoate | Generator | | Anhydro-O-sulphaminebenzoate | Generator | | Anhydro-O-sulphaminebenzoic acid | Generator | | Benzo-2-sulfimide | Generator | | Benzoate sulfimide | Generator | | Benzoate sulphimide | Generator | | Benzoic acid sulphimide | Generator | | Benzoylsulphonic imide | Generator | | O-Benzoic sulphimide | Generator | | O-Benzosulphimide | Generator | | O-Sulphobenzimide | Generator | | O-Sulfobenzoate imide | Generator | | O-Sulphobenzoate imide | Generator | | O-Sulphobenzoic acid imide | Generator | | 1, 2-Benzisothiazol-3(2H)-one, 1,1-dioxide | HMDB | | 1, 2-Benzisothiazolin-3-one 1,1-dioxide | HMDB | | 1, 2-dihydro-2-Ketobenzisosulfonazole | HMDB | | 1,1-Diox-1,2-benzisothiazol-3-one | HMDB | | 1,1-Dioxide-1,2-benzisothiazol-3(2H)-one | HMDB | | 1,1-Dioxide-1,2-benzisothiazolin-3-one | HMDB | | 1,1-dioxo-1,2-dihydro-1Lambda*6*-benzo[D]isothiazol-3-one | HMDB | | 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, 9ci | HMDB | | 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide | HMDB | | 1,2-Benzisothiazolin-3-one, 1,1-dioxide | HMDB | | 1,2-Benzisothiazoline-3-one 1,1-dioxide | HMDB | | 1,2-Benzothiazol-3(2H)-one 1,1-dioxide | HMDB | | 2, 3-dihydro-3-Oxobenzisosulfonazole | HMDB | | 2,3-dihydro-1,2-Benzoisothiazol-3-one-1,1-dioxide | HMDB | | 2,3-dihydro-3-oxo-Benzisosulfonazole | HMDB | | 2,3-Dihydroxy-1,2-benzisothiazol-3-one-1,1-dioxide | HMDB | | 2-Sulfobenzoic acid imide | HMDB | | 2-Sulfobenzoicimide | HMDB | | 2-Sulphobenzoic imide | HMDB | | 3-Benzisothiazolinone 1, 1-dioxide | HMDB | | 3-Benzisothiazolinone 1,1-dioxide | HMDB | | 3-Hydroxybenzisothiazole S,S-dioxide | HMDB | | benzo-2-Sulfiide | HMDB | | benzo-Sulphinide | HMDB | | Benzosulfinide | HMDB | | e954 | HMDB | | Garantose | HMDB | | Glucid | HMDB | | Gluside | HMDB | | Glycophenol | HMDB | | Hermesetas | HMDB | | Insoluble saccharin | HMDB | | Kandiset | HMDB | | LSA | HMDB | | Neosaccharin | HMDB | | O-Benzoic acid sulfimide | HMDB | | O-Benzoyl sulfimide | HMDB | | O-Benzoyl sulphimide | HMDB | | O-Benzoylsulfimide | HMDB | | O-Sulfobenzoic imide | HMDB | | Sacarina | HMDB | | Saccharin (JP15/nf) | HMDB | | Saccharin acid | HMDB | | Saccharin insoluble | HMDB | | Saccharin, insoluble | HMDB | | Saccharinol | HMDB | | Saccharinose | HMDB | | Saccharol | HMDB | | Sacharin | HMDB | | Stilalgin | HMDB | | Sucre edulcor | HMDB | | Sucrette | HMDB | | Syncal | HMDB | | Zaharina | HMDB | | Saccharin sodium | MeSH, HMDB | | Saccharin calcium | MeSH, HMDB | | Calcium, saccharin | MeSH, HMDB |
|
|---|
| Chemical Formula | C7H5NO3S |
|---|
| Average Molecular Weight | 183.185 |
|---|
| Monoisotopic Molecular Weight | 182.999013721 |
|---|
| IUPAC Name | 2,3-dihydro-1lambda6,2-benzothiazole-1,1,3-trione |
|---|
| Traditional Name | 2H-1lambda6,2-benzothiazole-1,1,3-trione |
|---|
| CAS Registry Number | 81-07-2 |
|---|
| SMILES | OC1=NS(=O)(=O)C2=CC=CC=C12 |
|---|
| InChI Identifier | InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9) |
|---|
| InChI Key | CVHZOJJKTDOEJC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzothiazoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzothiazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-benzothiazole
- Benzenoid
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 224 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 4 mg/mL at 25 °C | Not Available | | LogP | 0.91 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.94 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.8522 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.17 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 56.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1389.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 364.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 101.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 224.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 84.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 367.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 343.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 191.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 802.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 269.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1088.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 250.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 317.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 600.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 226.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 221.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|